![](https://ml-eu.globenewswire.com/media/f4e9f3e3-d828-44e5-8b52-db2582433db4/small/nodthera-logo-jpg.jpg)
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech Philadelphia, PA, August 5, 2024 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 …